Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.
Gillespie, D
Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements. [electronic resource] - In vivo (Athens, Greece) - 375-81 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0258-851X
Antiviral Agents--adverse effects
Colony-Forming Units Assay
Drug Resistance
Drug Synergism
Drug Therapy, Combination
HIV--drug effects
HIV Infections--drug therapy
Hematopoietic Stem Cells--drug effects
Humans
Poly I-C--adverse effects
Poly U--adverse effects
RNA, Double-Stranded
Zidovudine--adverse effects
Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements. [electronic resource] - In vivo (Athens, Greece) - 375-81 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0258-851X
Antiviral Agents--adverse effects
Colony-Forming Units Assay
Drug Resistance
Drug Synergism
Drug Therapy, Combination
HIV--drug effects
HIV Infections--drug therapy
Hematopoietic Stem Cells--drug effects
Humans
Poly I-C--adverse effects
Poly U--adverse effects
RNA, Double-Stranded
Zidovudine--adverse effects